Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1981 Aug;44(2):271–315.

British Association for Cancer Research 22nd Annual general meeting. 13-15 April 1981. Abstracts.

PMCID: PMC2010731  PMID: 7272193

Full text

PDF
271

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alberts D. S., Chang S. Y., Chen H. S., Larcom B. J., Jones S. E. Pharmacokinetics and metabolism of chlorambucil in man: a preliminary report. Cancer Treat Rev. 1979 Jun;6 (Suppl):9–17. doi: 10.1016/s0305-7372(79)80005-5. [DOI] [PubMed] [Google Scholar]
  2. Alberts D. S., Chen H. S., Mayersohn M., Perrier D., Moon T. E., Gross J. F. Bleomycin pharmacokinetics in man. II. Intracavitary administration. Cancer Chemother Pharmacol. 1979;2(2):127–132. doi: 10.1007/BF00254085. [DOI] [PubMed] [Google Scholar]
  3. Alberts D. S., Samon S. E., Chen H. S., Surwit E. A., Soehnlen B., Young L., Moon T. E. In-vitro clonogenic assay for predicting response of ovarian cancer to chemotherapy. Lancet. 1980 Aug 16;2(8190):340–342. doi: 10.1016/s0140-6736(80)90340-2. [DOI] [PubMed] [Google Scholar]
  4. Allen R. C., Stjernholm R. L., Steele R. H. Evidence for the generation of an electronic excitation state(s) in human polymorphonuclear leukocytes and its participation in bactericidal activity. Biochem Biophys Res Commun. 1972 May 26;47(4):679–684. doi: 10.1016/0006-291x(72)90545-1. [DOI] [PubMed] [Google Scholar]
  5. BURCHENAL J. H., KARNOFSKY D. A., MYERS W. P. L. The hepatotoxic action of N-methylformamide in man. Cancer. 1956 Sep-Oct;9(5):949–954. doi: 10.1002/1097-0142(195609/10)9:5<949::aid-cncr2820090514>3.0.co;2-k. [DOI] [PubMed] [Google Scholar]
  6. Barlow J. J., Piver M. S. Single agent vs combination chemotherapy in the treatment of ovarian cancer. Obstet Gynecol. 1977 May;49(5):609–611. [PubMed] [Google Scholar]
  7. Berry R. J., Laing A. H., Wells J. Fresh explant culture of human tumours in vitro and the assessment of sensitivity to cytotoxic chemotherapy. Br J Cancer. 1975 Feb;31(2):218–227. doi: 10.1038/bjc.1975.28. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Bischoff K. B., Dedrick R. L., Zaharko D. S., Longstreth J. A. Methotrexate pharmacokinetics. J Pharm Sci. 1971 Aug;60(8):1128–1133. doi: 10.1002/jps.2600600803. [DOI] [PubMed] [Google Scholar]
  9. Carswell E. A., Old L. J., Kassel R. L., Green S., Fiore N., Williamson B. An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci U S A. 1975 Sep;72(9):3666–3670. doi: 10.1073/pnas.72.9.3666. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Chu Y. H., Craig A. W., O'Connor P. J. Repair of O6-methylguanine in rat liver DNA is enhanced by pretreatment with single or multiple doses of aflatoxin B1. Br J Cancer. 1981 Jun;43(6):850–855. doi: 10.1038/bjc.1981.124. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Cobb L. M., Connors T. A., Elson L. A., Khan A. H., Mitchley B. C., Ross W. C., Whisson M. E. 2,4-dinitro-5-ethyleneiminobenzamide (CB 1954): a potent and selective inhibitor of the growth of the Walker carcinoma 256. Biochem Pharmacol. 1969 Jun;18(6):1519–1527. doi: 10.1016/0006-2952(69)90267-6. [DOI] [PubMed] [Google Scholar]
  12. Coffey J. J., White C. A., Lesk A. B., Rogers W. I., Serpick A. A. Effect of allopurinol on the pharmacokinetics of 6-mercaptopurine (NSC 755) in cancer patients. Cancer Res. 1972 Jun;32(6):1283–1289. [PubMed] [Google Scholar]
  13. Connors T. A., Cox P. J., Farmer P. B., Foster A. B., Jarman M. Some studies of the active intermediates formed in the microsomal metabolism of cyclophosphamide and isophosphamide. Biochem Pharmacol. 1974 Jan 1;23(1):115–129. doi: 10.1016/0006-2952(74)90318-9. [DOI] [PubMed] [Google Scholar]
  14. Cumber A. J., Ross W. C. Analogues of hexamethylmelamine. The anti-neoplastic activity of derivatives with enhanced water solubility. Chem Biol Interact. 1977 Jun;17(3):349–357. doi: 10.1016/0009-2797(77)90097-7. [DOI] [PubMed] [Google Scholar]
  15. Currie G. A., Basham C. Serum mediated inhibition of the immunological reactions of the patient to his own tumour: a possible role for circulating antigen. Br J Cancer. 1972 Dec;26(6):427–438. doi: 10.1038/bjc.1972.59. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Dedrick R. L., Forrester D. D., Ho D. H. In vitro-in vivo correlation of drug metabolism--deamination of 1- -D-arabinofuranosylcytosine. Biochem Pharmacol. 1972 Jan;21(1):1–16. doi: 10.1016/0006-2952(72)90245-6. [DOI] [PubMed] [Google Scholar]
  17. Dendy P. P., Bozman G., Wheeler T. K. In-vitro screening test for human malignant tumours before chemotherapy. Lancet. 1970 Jul 11;1(7663):68–72. doi: 10.1016/s0140-6736(70)92640-1. [DOI] [PubMed] [Google Scholar]
  18. Edwards P. A., Easty D. M., Foster C. S. Selective culture of epithelioid cells from a human squamous carcinoma using a monoclonal antibody to kill fibroblasts. Cell Biol Int Rep. 1980 Oct;4(10):917–922. doi: 10.1016/0309-1651(80)90193-9. [DOI] [PubMed] [Google Scholar]
  19. Finj C., Sadée W. Determination of 5-fluorouracil (NSC-19893) plasma levels in rats and man by isotope dilution-mass fragmentography. Cancer Chemother Rep. 1975 Mar-Apr;59(2 Pt 1):279–286. [PubMed] [Google Scholar]
  20. Freshney R. I., Paul J., Kane I. M. Assay of anti-cancer drugs in tissue culture: conditions affecting their ability to incorporate 3H-leucine after drug treatment. Br J Cancer. 1975 Jan;31(1):89–99. doi: 10.1038/bjc.1975.11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Galasko C. S., Sylvester B. S. Back pain in patients treated for malignant tumours. Clin Oncol. 1978 Sep;4(3):273–283. [PubMed] [Google Scholar]
  22. Harris J. R., Timberlake N., Henson P., Schimke P., Belli J. A. Adriamycin uptake in V79 and adriamycin resistant Chinese hamster cells. Int J Radiat Oncol Biol Phys. 1979 Aug;5(8):1235–1239. doi: 10.1016/0360-3016(79)90645-x. [DOI] [PubMed] [Google Scholar]
  23. Harris P. A., Gross J. F. Preliminary pharmacokinetic model for adriamycin (NSC-123127). Cancer Chemother Rep. 1975 Jul-Aug;59(4):819–825. [PubMed] [Google Scholar]
  24. Heyderman E., Neville A. M. A shorter immunoperoxidase technique for the demonstration of carcinoembryonic antigen and other cell products. J Clin Pathol. 1977 Feb;30(2):138–140. doi: 10.1136/jcp.30.2.138. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Holmes H. L., Little J. M. Tissue-culture microtest for predicting response of human cancer to chemotherapy. Lancet. 1974 Oct 26;2(7887):985–987. doi: 10.1016/s0140-6736(74)92075-3. [DOI] [PubMed] [Google Scholar]
  26. Huber P. R., Geyer E., Küng W., Matter A., Torhorst J., Eppenberger U. Retinoic acid-binding protein in human breast cancer and dysplasia. J Natl Cancer Inst. 1978 Dec;61(6):1375–1378. [PubMed] [Google Scholar]
  27. Ioachim H. L., Sabbath M., Andersson B., Barber H. R. Tissue cultures of ovarian carcinomas. Lab Invest. 1974 Oct;31(4):381–390. [PubMed] [Google Scholar]
  28. Kinsella A. R., Radman M. Tumor promoter induces sister chromatid exchanges: relevance to mechanisms of carcinogenesis. Proc Natl Acad Sci U S A. 1978 Dec;75(12):6149–6153. doi: 10.1073/pnas.75.12.6149. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Lieberman A., LeBrun Y., Glass P., Goodgold A., Lux W., Wise A., Ransohoff J. Use of high dose corticosteroids in patients with inoperable brain tumours. J Neurol Neurosurg Psychiatry. 1977 Jul;40(7):678–682. doi: 10.1136/jnnp.40.7.678. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Limburg H., Heckmann U. Chemotherapy in the treatment of advanced pelvic malignant disease with special reference to ovarian cancer. J Obstet Gynaecol Br Commonw. 1968 Dec;75(12):1246–1255. doi: 10.1111/j.1471-0528.1968.tb02931.x. [DOI] [PubMed] [Google Scholar]
  31. Malkasian G. D., Jr, Decker D. G., Jorgensen E. O., Edmonson J. H. Medroxyprogesterone acetate for the treatment of metastatic and recurrent ovarian carcinoma. Cancer Treat Rep. 1977 Aug;61(5):913–914. [PubMed] [Google Scholar]
  32. Meares A. Meditation: a psychological approach to cancer treatment. Practitioner. 1979 Jan;222(1327):119–122. [PubMed] [Google Scholar]
  33. Millar J. L., McElwain T. J. Combinations of cytotoxic agents that have less than expected toxicity on normal tissues in mice. Antibiot Chemother (1971) 1978;23:271–282. doi: 10.1159/000401490. [DOI] [PubMed] [Google Scholar]
  34. Olin G. R., Ahlbom A. The cancer mortality among Swedish chemists graduated during three decades. A comparison with the general population and with a cohort of architects. Environ Res. 1980 Jun;22(1):154–161. doi: 10.1016/0013-9351(80)90127-9. [DOI] [PubMed] [Google Scholar]
  35. Olson R. D., MacDonald J. S., vanBoxtel C. J., Boerth R. C., Harbison R. D., Slonim A. E., Freeman R. W., Oates J. A. Regulatory role of glutathione and soluble sulfhydryl groups in the toxicity of adriamycin. J Pharmacol Exp Ther. 1980 Nov;215(2):450–454. [PubMed] [Google Scholar]
  36. Owellen R. J., Hartke C. A., Hains F. O. Pharmacokinetics and metabolism of vinblastine in humans. Cancer Res. 1977 Aug;37(8 Pt 1):2597–2602. [PubMed] [Google Scholar]
  37. Owellen R. J., Root M. A., Hains F. O. Pharmacokinetics of vindesine and vincristine in humans. Cancer Res. 1977 Aug;37(8 Pt 1):2603–2607. [PubMed] [Google Scholar]
  38. Palan P. R., Romney S. L. Cellular binding proteins for vitamin A in human carcinomas and in normal tissues. Cancer Res. 1980 Nov;40(11):4221–4224. [PubMed] [Google Scholar]
  39. Patton T. F., Himmelstein K. J., Belt R., Bannister S. J., Sternson L. A., Repta A. J. Plasma levels and urinary excretion of filterable platinum species following bolus injection and iv infusion of cis-dichlorodiammineplatinum(II) in man. Cancer Treat Rep. 1978 Sep;62(9):1359–1362. [PubMed] [Google Scholar]
  40. Pegg A. E., Hui G. Formation and subsequent removal of O6-methylguanine from deoxyribonucleic acid in rat liver and kidney after small doses of dimethylnitrosamine. Biochem J. 1978 Sep 1;173(3):739–748. doi: 10.1042/bj1730739. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Rutty C. J., Connors T. A. In vitro studies with hexamethylmelamine. Biochem Pharmacol. 1977 Dec 15;26(24):2385–2391. doi: 10.1016/0006-2952(77)90446-4. [DOI] [PubMed] [Google Scholar]
  42. Rutty C. J., Connors T. A., Nguyen-Hoang-Nam, Do-Cao-Thang, Hoellinger H. In vivo studies with hexamethylmelamine. Eur J Cancer. 1978 Jun;14(6):713–720. doi: 10.1016/0014-2964(78)90308-0. [DOI] [PubMed] [Google Scholar]
  43. Saleh A. M., Pheasant A. E., Blair J. A., Allan R. N. The effect of malignant disease on the metabolism of pteroylglutamic acid in man. Biochem Soc Trans. 1980 Oct;8(5):566–567. doi: 10.1042/bst0080566. [DOI] [PubMed] [Google Scholar]
  44. Schabel F. M., Jr, Trader M. W., Laster W. R., Jr, Wheeler G. P., Witt M. H. Patterns of resistance and therapeutic synergism among alkylating agents. Antibiot Chemother (1971) 1978;23:200–215. doi: 10.1159/000401484. [DOI] [PubMed] [Google Scholar]
  45. Shorthouse A. J., Smyth J. F., Steel G. G., Ellison M., Mills J., Peckham M. J. The human tumour xenograft--a valid model in experimental chemotherapy? Br J Surg. 1980 Oct;67(10):715–722. doi: 10.1002/bjs.1800671011. [DOI] [PubMed] [Google Scholar]
  46. Sundström C., Nilsson K. Establishment and characterization of a human histiocytic lymphoma cell line (U-937). Int J Cancer. 1976 May 15;17(5):565–577. doi: 10.1002/ijc.2910170504. [DOI] [PubMed] [Google Scholar]
  47. Tattersall M. H., Sodergren J. E., Dengupta S. K., Trites D. H., Modest E. J., Frei E., 3rd Pharmacokinetics of actinoymcin D in patients with malignant melanoma. Clin Pharmacol Ther. 1975 Jun;17(6):701–708. doi: 10.1002/cpt1975176701. [DOI] [PubMed] [Google Scholar]
  48. Theologides A. Cancer cachexia. Cancer. 1979 May;43(5 Suppl):2004–2012. doi: 10.1002/1097-0142(197905)43:5+<2004::aid-cncr2820430708>3.0.co;2-#. [DOI] [PubMed] [Google Scholar]
  49. Tisdale M. J. Effect of methionine replacement by homocysteine on the growth of cells. Cell Biol Int Rep. 1980 Jun;4(6):563–570. doi: 10.1016/0309-1651(80)90022-3. [DOI] [PubMed] [Google Scholar]
  50. WRIGHT J. C., COBB J. P., GUMPORT S. L., GOLOMB F. M., SAFADI D. Investigation of the relation between clinical and tissue-culture response to chemotherapeutic agents on human cancer. N Engl J Med. 1957 Dec 19;257(25):1207–1211. doi: 10.1056/NEJM195712192572502. [DOI] [PubMed] [Google Scholar]
  51. Weibel E. R. Stereological principles for morphometry in electron microscopic cytology. Int Rev Cytol. 1969;26:235–302. doi: 10.1016/s0074-7696(08)61637-x. [DOI] [PubMed] [Google Scholar]
  52. Wheeler T. K., Dendy P. P., Dawson A. Assessment of an in vitro screening test of cytotoxic agents in the treatment of advanced malignant disease. Oncology. 1974;30(5):362–376. doi: 10.1159/000224977. [DOI] [PubMed] [Google Scholar]
  53. Whiting B., Miller S. H., Caddy B. A procedure for monitoring cyclophosphamide and isophosphamide in biological samples. Br J Clin Pharmacol. 1978 Oct;6(4):373–376. doi: 10.1111/j.1365-2125.1978.tb00869.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES